Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

The R&D of CD20/CD3 Bispecific Antibody in China

Yefenghong/PharmaSourcesMarch 01, 2023

Tag: Bispecific , Biopharma , GB261

PharmaSources Customer Service